Abstract:OBJECTIVE To assess the effects of blood pressure lowering treatments for the prevention of cognitive decline on primary hypertension patients with vascular cognitive impairment,and to investigate whether those patients could benefit from the treatment of atorvastatin in addition to blood pressure lowering treatments.METHODS 143 primary hypertension patients with vascular cognitive impairment were allocated into three groups.Patients in Group A (n=57),with hypercholesterolemia,undertook blood pressure lowering treatments and atorvastatin.The others,with normal plasma cholesterol levels,were randomly divided into two subgroups.Patients in Group B1 (n=42),undertook blood pressure lowering treatments and placebo.Patients in Group B2 (n=44),undertook blood pressure lowering treatments and atorvastatin.At baseline and 1 year after treatment,cognitive function was evaluated by using MMSE scale,ADAS-cog scale and SF-36 scale.RESULTS After treatment,all patients had significantly increase on the MMSE scores and the SF-36 scores between the baseline scores and the final socres,and they also had significantly decrease on the ADAS-cog scores.There were no significant difference in the alteration of the MMSE scores and the ADAS-cog scores between Group B1 and Group B2.The increase of the SF-36 scores in Group B2 was more significant than Group B1.The increase of the MMSE scores and the SF-36 scores in Group A were more significant than those of Group B2.And the decreases of the ADAS-cog scores in Group A was more significant than those of Group B2.CONCLUSION Blood pressure lowering treatments can improve cognitive function and life quality in primary hypertension patients with vascular cognitive impairment.Primary hypertension patients with normal plasma cholesterol levels can not have more benefit to cognitive function from the the treatment of atorvastatin in addition to blood pressure lowering treatments,in spite of improving the life quality.However,primary hypertension patients with hypercholesterolemia can have more benefit to cognitive function from the the treatment of atorvastatin in addition to blood pressure lowering treatments.

Effects of the Atorvastatin to blood lipid and C-reactive protein in cerebral infarct

The effect of simvastatin on C reactive protein in patients with coronary heart disease

Clinical Observation about Effection of Atorvastatin on Preventing Renal Function in Patients with Coronary Heart Disease and Diabetes Mellitus

Effects of HMG-CoA Reductase Inhibitors on Primary Hypertension Patients with Vascular Cognitive Impairment

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

Effects of Pravastatin on Serum Ox-Ldl,tgf-β1,vcam-1 and Lipid Levels in Patients with Acute Cerebral Infarction

Effects of Atorvastatin on Interleukin-1 and C-reactive Protein Levels of Patients with Acute Myocardial Infarction

Effect of atorvastatin on cognition and blood lipids in patients with different stages of vascular cognitive impairment

Effect of pitavastatin and atorvastatin on regulation of lipid in ischemic stroke patients

Influence of atorvastatin to oxidative stress indexes and carotid arterial plaques in acute cereal infarction patients

Study of curative effect of acute coronary syndrome by intensive atorvastatin therapy

Effects of atorvastatin on patients with transient ischemic attack

Effect of Simvastatin on Acute Coronary Syndrome Complicated with Atrial Fibrillation

Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults

Statins Therapy for C-reactive Protein and Carotid Intima-Media Thickness in Patients with Cerebral Infarction:A Systematic Review

Effects of Pravastatine on Blood Lipid and Hemorheology of Patients with Acute Ischemic Cerebral Stoke

Clinical Study of Atorvastatin Combined with Clopidogrel in Patients with Acute Cerebral Infarction

Effect of Different Doses of Atorvastatin on Early Neurological Deterioration and Short-Term Outcomes in Patients with Acute Ischemic Stroke

The Effect of Simvastatin and Pravastatin on Serum Lipid and C Reactive Protein in Patients with Acute Coronary Syndrome

Cerebral Blood Flow Evaluation of Intensive Rosuvastatin Therapy in Stroke/Transient Ischemic Attack Patients with Intracranial Arterial Atherosclerotic Stenosis Study: Rationale and Design

Clinic study on anti-inflammatory effects of atorvastatin associated with rampril in patients with acute coronary syndrome